OR-AIRSHIP
16.11.2023 15:01:37 CET | Business Wire | Press release
As organizations rush to adopt AI, a data-driven focus is foundational — not only to fuel better AI, but to avoid sacrificing long-term customer value for short-term gains. Nowhere is this more important than in mobile app experience, where value creation opportunities are 3-4X greater than anywhere else.
Today, mobile app experience company Airship introduced a host of enhancements to make continuous experimentation and optimization even easier.
From optimizing the performance of cross-channel customer journeys to refining messages, campaigns and no-code native app experiences, to testing app user experience and features themselves, all Airship experiments are now centralized in an Experimentation Hub. It’s a dashboard that anyone can use to create, launch and evaluate experiments and obtain a common understanding of the end-to-end experimentation and optimization strategy.
Holdout Experiments take A/B testing and control groups to a new level, allowing marketers to measure their impact on business goals by comparing audiences that receive marketing-led experiences versus those that don’t. Feature Flags enable teams to turn functionality on and off, run tests with control groups, activate short-term campaigns and make iterative experience enhancements before rolling them out to full audiences — all without the need for new code deployment or app store updates.
Airship has also centralized its visual reporting environment, providing real-time insights from all active experiments, as well as customer, channel and campaign data, into one place. A new App Health Reporting dashboard provides at-a-glance KPIs to help marketers and product owners understand app performance across the mobile app lifecycle.
Register to join two leading brand experts as they explore how continuous experimentation and optimization drives better results for businesses in a December 5 webinar.
Since the introduction of Airship’s no-code native App Experience Editor, businesses around the world have enabled non-technical teams to easily create, automate and adapt native app experiences for continuous onboarding and first-party and zero-party data collection. Numerous nominations for Airship’s annual customer awards program — The Altitude Awards — have documented their successes with agile creation and experimentation, including:
“Experimentation is fully integrated into Burger King France’s strategy, as we strive to deliver personalized, innovative experiences across all channels, from campaigns to product testing and new services,” said Valentin Pereira, CRM Project Manager. “Airship’s no-code native app experiences make it easy to go beyond messaging to optimize critical multiscreen app flows as well as important customer journeys and multi-channel campaigns. Results of initial app experience tests will have us repeating Airship Stories and videos at key moments in the customer journey — from welcoming new app users to launching major sales promotions.”
“Olio is fighting climate change by connecting people everywhere to give away rather than throw away, and share rather than shop, which makes our mobile app and notification opt-ins critical to facilitating rapid sharing and exchanges,” said Gareth Main, Chief Customer Officer at Olio. “Airship’s no-code native app experiences have enabled our entire team to quickly take action and experiment to improve users’ experiences, including recent tests that grew our notification opt-in rate by 24% while identifying a new approach we’ll take for future campaigns.”
“With more than 10 apps in total, we measure customer satisfaction daily. Previously, we used an HTML webview to deliver surveys to app users, which proved to be a distracting experience, resulting in low response rates,” said Laurent Claramonte, head of data analytics for Products and Mobile Apps, Orange France. “Since moving to Airship’s no-code native app experiences to quickly deploy, test and adapt onboarding flows, surveys and more, we now get as many customer survey responses in a day as we used to receive in a month.”
Winners of Airship’s Altitude Awards will be announced at Mobile Leaders Forum London later today.
“Customers’ first experiences with brands have an outsized impact on future value, especially when it comes to mobile app experiences where more than half decide whether to delete a new app in the first two uses,” said Brett Caine, CEO and president, Airship. “Brands need to recognize the limited window they have to make a compelling case for app customers to stick around. With Airship’s solution approach we are streamlining creation, experimentation and optimization, giving brands the keys to unlock agile optimization and more quickly achieve their business goals.”
About Airship
No one knows more, does more, or cares more than Airship when it comes to helping brands master mobile app experience (MAX).
From the beginning of apps, Airship powered the first commercial messages and then expanded its data-led approach to all re-engagement channels (mobile wallet, SMS, email), app UX experimentation, no-code native app experience creation and App Store Optimization (ASO).
Having powered trillions of mobile app interactions for thousands of global brands, Airship’s technology and deep industry expertise have enabled apps to become the digital center of customer experience, brand loyalty and monetization.
With the Airship App Experience Platform and Gummicube’s ASO technology and expertise, brands now have a complete set of solutions to optimize the entire mobile app customer journey – from the point of discovery to loyalty – driving greater value for everyone involved.
For more information, visit www.airship.com, read our blog or follow us on X (formerly Twitter), LinkedIn and Facebook.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231116362912/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 10:00:00 CEST | Press release
REACH study met its first primary endpoint, showing that Broncho‑Vaxom® (OM‑85) was associated with a 28-38% reduction in respiratory tract infection rates at 12 months and 29-41% reduction at 24 months, comparing post-treatment versus pre-treatment initiation.1 The reduction was observed regardless of the frequency of respiratory tract infections in the previous year (1-3, >3) and across age subgroups (1-5, 6-11, 12-17, 18-64, >64 years).1 By reflecting everyday clinical practice and capturing episodes that necessitated a visit to the doctor, these extensive data offer critical new evidence of the therapy’s long-term relevance for patients suffering from recurrent respiratory tract infections. Evaluating a vast cohort of more than 15,790 paediatric, adolescent, adult and elderly patients in China, Italy, and Belgium, REACH represents the largest and only multi-country real-world evidence study to date for Broncho-Vaxom®.1,2 The study cohort includes patients with different co-morbidit
Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 17:15:00 CEST | Press release
In myelofibrosis (MF), INCA033989 delivered rapid and durable clinical benefits including meaningful spleen volume reductions, symptom improvement and anemia responses, both as a monotherapy and in combination with ruxolitinibIn essential thrombocythemia (ET), 87% of patients achieved a hematologic response, including 70% complete responses; responses were rapid (median ~2 weeks to a durable complete hematologic response) and durable (median response duration of 23 weeks)Across MF and ET, INCA033989 consistently reduced mutant CALR (mutCALR) variant allele frequency (VAF) in most evaluable patients, with reductions correlating with clinical responses and supporting its potential for disease modificationFirst-in-class mutCALR-targeted antibody shows potential to modify disease biology in both MF and ETINCA033989 demonstrated a favorable and manageable safety profile with no dose-limiting toxicities, with most patients with MF and ET continuing treatment Incyte (Nasdaq:INCY) today announ
Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi®/Minjuvi®) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 12:00:00 CEST | Press release
- frontMIND study evaluating tafasitamab (Monjuvi®/Minjuvi®) in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL) selected for the prestigious Plenary Abstracts Session at EHA 2026 - Results showed tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) significantly prolonged progression-free survival (PFS), reducing risk of disease progression or death by 25% - Positive trends toward PFS benefit with Tafa-Len-R-CHOP were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypes - The frontMIND data support global regulatory applications for tafasitamab and lenalidomide in addition to R-CHOP for previously untreated DLBCL and HGBL Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified c
Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202612.6.2026 23:31:00 CEST | Press release
Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til
IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 18:36:00 CEST | Press release
Venneman brings more than 30 years of digital transformation, AI, and enterprise technology experience as IQM prepares for its planned Nasdaq listing IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
